Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Kathleen, Mieras"'
Autor:
Paul A. Monach, E W St Clair, Paul Brunetta, Eugene Y. Kissin, Steven R. Ytterberg, Philip Seo, Brett Jepson, Coen A. Stegeman, Peter A. Merkel, Gary S. Hoffman, Fernando C. Fervenza, Robert Spiera, David Ikle, Tobias Peikert, Linna Ding, Duvuru Geetha, N. K. Tchao, Cees G. M. Kallenberg, Eli M. Miloslavsky, Lisa Viviano, Carol A. Langford, Karina A. Keogh, Lourdes P. Sejismundo, Nancy B. Allen, John H. Stone, Mark Mueller, Kathleen Mieras, Ulrich Specks
Publikováno v:
Arthritis & Rheumatism. 65:2441-2449
Objective. To evaluate the reasons that complete remission is not achieved or maintained with original treatment in some patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) treated with rituximab (RTX) or with cycloph
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::43219159fd73a2cae70a4be4670fa460
https://doi.org/10.1002/art.38044
https://doi.org/10.1002/art.38044
Autor:
Craig E, Daniels, Joseph A, Lasky, Andrew H, Limper, Kathleen, Mieras, Edith, Gabor, Darrell R, Schroeder, Jo Ann, Duffy
Publikováno v:
American Journal of Respiratory and Critical Care Medicine. 181:604-610
Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease with no known efficacious therapy. Imatinib is a tyrosine kinase inhibitor with potential efficacy to treat fibrotic lung disease.To investigate the safety and clinical effects of imat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16dec0a288e6f8565c7a0f6572c7a059
https://doi.org/10.1164/rccm.200906-0964oc
https://doi.org/10.1164/rccm.200906-0964oc
Autor:
Ulrich, Specks, Peter A, Merkel, Philip, Seo, Robert, Spiera, Carol A, Langford, Gary S, Hoffman, Cees G M, Kallenberg, E William, St Clair, Barri J, Fessler, Linna, Ding, Lisa, Viviano, Nadia K, Tchao, Deborah J, Phippard, Adam L, Asare, Noha, Lim, David, Ikle, Brett, Jepson, Paul, Brunetta, Nancy B, Allen, Fernando C, Fervenza, Duvuru, Geetha, Karina, Keogh, Eugene Y, Kissin, Paul A, Monach, Tobias, Peikert, Coen, Stegeman, Steven R, Ytterberg, Mark, Mueller, Lourdes P, Sejismundo, Kathleen, Mieras, John H, Stone, Adelaide N, Archampong
Publikováno v:
New England Journal of Medicine, 369(5), 417-427. MASSACHUSETTS MEDICAL SOC
The 18-month efficacy of a single course of rituximab as compared with conventional immunosuppression with cyclophosphamide followed by azathioprine in patients with severe (organ-threatening) antineutrophil cytoplasmic antibody (ANCA)-associated vas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7de7d9c5defb2cc396d0b86c86bd9a7d
https://research.rug.nl/en/publications/1164481d-d618-4fb5-8c25-359fcc714ae6
https://research.rug.nl/en/publications/1164481d-d618-4fb5-8c25-359fcc714ae6
Autor:
Paul A. Monach, Coen A. Stegeman, Peter A. Merkel, Nadia K. Tchao, Tobias Peikert, Eugene Y. Kissin, Vicki Seyfert-Margolis, E. William St. Clair, Linna Ding, Steven R. Ytterberg, Kathleen Mieras, David Weitzenkamp, Fernando C. Fervenza, Mark Mueller, Lourdes P. Sejismundo, Gary S. Hoffman, Ulrich Specks, Anthony M. Turkiewicz, Cees G. M. Kallenberg, John H. Stone, Robert Spiera, Nancy B. Allen, Paul Brunetta, Karina A. Keogh, Lisa Webber, Carol A. Langford, David Ikle, Duvuru Geetha, Philip Seo
Publikováno v:
New England Journal of Medicine, 363(3), 221-232. MASSACHUSETTS MEDICAL SOC
Background Cyclophosphamide and glucocorticoids have been the cornerstone of remissioninduction therapy for severe antineutrophil cytoplasmic antibody (ANCA)−associated vasculitis for 40 years. Uncontrolled studies suggest that rituximab is effecti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b62c3557c1b0b5c4c0a8c06967a5586
https://research.rug.nl/en/publications/cde2051f-b51d-4ce3-8666-60562eb41d70
https://research.rug.nl/en/publications/cde2051f-b51d-4ce3-8666-60562eb41d70